Alopecia, hair loss
BioMG follows French guidelines. Adapt it to the guidelines and the tests available where you practise.
Approach: what type of alopecia?
Laboratory tests
- No routine tests for hair loss: the prescription depends on the clinical form (see the following tabs).
Do not order
- Routine “hair loss work-up” (FBC, ferritin, TSH as a set): there is no routine test; laboratory tests are discussed when the history or examination points to an underlying disease [2].
- Vitamin D: outside rickets, osteomalacia, bariatric surgery, repeated falls in older people and a few other situations, the NABM considers its measurement useless [8].
Diffuse hair loss (telogen effluvium)
Laboratory tests
- Serum ferritin (if clinical suggestion or deficiency factor)if needednon-French guidelineLooking for iron deficiency, one of the discussed triggers; threshold and value of supplementation remain debated [9,10]. The American Family Physician review measures it on clinical grounds [2].
- TSH (if clinical suggestion)if needednon-French guidelineThyroid dysfunction is among the triggers: an Indian consensus puts TSH in its baseline tests [9], and the Androgen Excess and PCOS Society calls it optional but recommended in female alopecia [11]. The American Family Physician review measures it on clinical grounds [2].
- FBCif needednon-French guidelinePlaced by an Indian expert consensus in the baseline tests of any diffuse hair loss [9]; weak evidence.
- Syphilis serology (if irregular "moth-eaten" patches or risk factor for STI)if neededMultiple, irregular, “moth-eaten” patches of alopecia (clearings), or diffuse thinning, in an exposed patient or with other signs of secondary syphilis: syphilitic alopecia affects 2.9 to 7% of secondary syphilis and is confused with alopecia areata, tinea capitis or telogen effluvium [3].
Do not order
- Zinc: data linking zinc to telogen effluvium or androgenetic alopecia are too heterogeneous, its measurement is not recommended [10]; the NABM, moreover, limits it to specific situations (parenteral nutrition, acrodermatitis, IBD, malnutrition in children…) [8].
- Selenium: no data justify measuring it [10].
- Vitamin D: outside rickets, osteomalacia, bariatric surgery, repeated falls in older people and a few other situations, the NABM considers its measurement useless [8].
Female androgenetic alopecia
Laboratory tests
- Total testosterone (if looking for hyperandrogenism)if needednon-French guidelineThe Androgen Excess and PCOS Society (2019) considers it mandatory to look for androgen excess in every affected woman [11]. The international PCOS guideline (2023) points out that isolated alopecia, without hirsutism, is a poor predictor of biochemical hyperandrogenism [12]. The American Family Physician review does not propose hormonal tests in women [2].
- SHBG (if testosterone is measured, to calculate the free androgen index)if needednon-French guidelineWith testosterone, to calculate the free androgen index [12]. Same positions as for testosterone [2,11,12].
- Serum prolactin (if looking for hyperandrogenism)if needednon-French guidelineCalled optional but recommended by the Androgen Excess and PCOS Society, of uncertain value: 7.2% raised prolactin and 1.8% prolactinoma in a series of 109 women [11].
- TSH (if clinical suggestion)if needednon-French guidelineCalled optional but recommended by the Androgen Excess and PCOS Society [11]. The American Family Physician review does not propose hormonal tests in women [2].
- Serum ferritin (if clinical suggestion or deficiency factor)if needednon-French guidelineIron is called optional but recommended by the Androgen Excess and PCOS Society [11]. The American Family Physician review measures it on clinical grounds [2].
- Delta-4-androstenedione (if testosterone normal)if needednon-French guidelineNormal total and free testosterone while hyperandrogenism is still suspected: androstenedione may be measured, less specific [12].
- DHEA-S (if testosterone normal)if needednon-French guidelineNormal total and free testosterone: DHEA-S may be measured, less specific and falls with age [12].
- 17-hydroxyprogesterone (if androgens very high)if needednon-French guidelineAndrogens well above normal: look for a cause other than PCOS, including congenital adrenal hyperplasia, an ovarian or adrenal tumour, Cushing's syndrome [12].
- On the combined oestrogen-progestogen pill, androgens cannot be interpreted: if the assay is essential, stop the pill for at least 3 months (other contraception in the meantime).
Also consider
- Hirsutism or irregular cycles? For the work-up of hyperandrogenism, see also the Hirsutism page.
Men: androgenetic alopecia
Laboratory tests
- Typical form (gradual onset, family history, temporal recession, vertex, normal scalp): no tests, including before finasteride or minoxidil.
- Sudden, diffuse or patchy hair loss, abnormal scalp or general signs: this is not typical androgenetic alopecia; see the tabs "Diffuse hair loss (telogen effluvium)", "Alopecia areata" or "Scarring or inflammatory alopecia".
Do not order
- Testosterone, hormone tests: male pattern baldness does not depend on the blood androgen level, and laboratory tests are usually unnecessary [5].
- Routine tests (FBC, ferritin, TSH) in a typical form: history and examination make the diagnosis [2].
- Zinc: measurement not recommended in androgenetic alopecia [10]; NABM coverage limited to specific situations [8].
- Vitamin D: measurement considered useless by the NABM outside its indications [8].
Alopecia areata (patchy hair loss)
Laboratory tests
- No tests are needed in most cases of alopecia areata.
- TSH (adult with alopecia totalis or universalis, or child at risk)if needednon-French guidelineAdults: screening is debated, to be considered mainly in total or universal alopecia areata; children: only if trisomy 21 (Down syndrome), atopy, family history of thyroid disease or clinical signs [6].
- Anti-TPO antibodies (with the TSH, same indications)if needednon-French guidelineIf thyroid screening is done, the British recommendation pairs TSH with thyroid autoantibodies [6].
- Syphilis serology (if diagnostic doubt)if neededDiagnostic doubt: secondary syphilis can mimic alopecia areata [3,6].
Do not order
Child: patches of hair loss (tinea capitis)
Mycological examination (as soon as possible, without delaying treatment)
- Mycological sample from the scalp: broken hairs and scales, pus on a swab if kerion (direct examination and culture)
- Preferably before any antifungal. If an antifungal has already been applied, some laboratories ask for a break of 15 days (topical treatment) or 3 months (oral treatment): check with the laboratory, without delaying empirical treatment.
- ASTif neededRisk factor for liver damage: routine liver monitoring is not established in children, it is decided case by case [15,16].
- ALTif neededRisk factor for liver damage: routine liver monitoring is not established in children, it is decided case by case [15,16].
- GGTif neededRisk factor for liver damage: routine liver monitoring is not established in children, it is decided case by case [15,16].
Contacts
- Siblings and parents: scalp examination and mycological sample, as early as possible (prescription in each person's name). Pet: veterinarian, even if it looks healthy.
Also consider
- Tinea capitis suspected? If tinea capitis is suspected, take the mycological sample described in the corresponding page.
Do not order
- Routine liver function tests before terbinafine or itraconazole in a child without risk factors: value not established, decision case by case [15].
Scarring or inflammatory alopecia
Specialist opinion
- Refer to a dermatologist, who decides on a scalp biopsy: follicular openings lost (scarring alopecia) or inflamed scalp without an obvious diagnosis.
Laboratory tests (only if the context requires)
- Syphilis serology ("moth-eaten" patches or risk factor for STI)if neededIrregular “moth-eaten” patches or diffuse thinning in an exposed patient: syphilitic alopecia, non-scarring, mimics alopecia areata, tinea capitis or effluvium [3]; secondary syphilis is among the differential diagnoses of tinea capitis [17].
- TSH (if lichen planopilaris or frontal fibrosing alopecia diagnosed)if needednon-French guidelineLichen planopilaris or frontal fibrosing alopecia confirmed by the dermatologist: hypothyroidism in 17 to 19% of patients in a meta-analysis of observational studies, whose authors propose thyroid tests in all [22]. Authors' proposal, not a recommendation.
- Discoid lupus, or signs of involvement of other organs: see the page "Systemic lupus: initial tests and laboratory monitoring in the community".
Also consider
- Moth-eaten patches, syphilis possible? Syphilitic alopecia is easily confused with alopecia areata or tinea capitis: see the Positive syphilis serology page to interpret the serology.
Sources (22)
- Rebora A. Telogen effluvium: a comprehensive review. Clin Cosmet Investig Dermatol. 2019;12:583-590.
- Phillips TG, Slomiany WP, Allison R. Hair loss: common causes and treatment. Am Fam Physician. 2017;96(6):371-378.
- Murthy AB, Palaniappan V, Elango RR, Karthikeyan K. Moth-eaten alopecia and beyond: syphilitic alopecia – revisited. Indian J Sex Transm Dis AIDS. 2024;45(2):144-147.
- Centre de référence du lupus, SAPL et autres maladies auto-immunes rares ; centre de référence RAISE ; filière FAI²R. Protocole national de diagnostic et de soins (PNDS) : lupus systémique de l'adulte et de l'enfant. Haute Autorité de santé, janvier 2024.
- Mysore V, Parthasaradhi A, Kharkar RD, et al. Expert consensus on the management of androgenetic alopecia in India. Int J Trichology. 2019;11(3):101-106.
- Harries MJ, Ascott A, Asfour L, et al. British Association of Dermatologists living guideline for managing people with alopecia areata 2024. Br J Dermatol. 2025;192(2):190-205 (section 6.1, investigations).
- Harries MJ, Ahmed A, Ascott A, et al. British Association of Dermatologists living guideline for managing people with alopecia areata 2024 (mise à jour de 2025). Br J Dermatol 2026;194(2):e56-e73.
- Assurance maladie. Nomenclature des actes de biologie médicale (NABM), version 105 : actes 1139 (25-OH-vitamine D), 2003 (zinc), 1802 (SDHEA), 1487 (anticorps anti-TPO).
- Mysore V, Parthasaradhi A, Kharkar RD, et al. Expert consensus on the management of telogen effluvium in India. Int J Trichology. 2019;11(3):107-112.
- Almohanna HM, Ahmed AA, Tsatalis JP, Tosti A. The role of vitamins and minerals in hair loss: a review. Dermatol Ther (Heidelb). 2019;9(1):51-70.
- Carmina E, Azziz R, Bergfeld W, et al. Female pattern hair loss and androgen excess: a report from the multidisciplinary Androgen Excess and PCOS Committee. J Clin Endocrinol Metab. 2019;104(7):2875-2891.
- Teede HJ, Tay CT, Laven J, Dokras A, Moran LJ, et al. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. Hum Reprod. 2023;38(9):1655-1679.
- Finastéride Biogaran 1 mg, comprimé pelliculé : résumé des caractéristiques du produit (rubriques 4.1 à 4.6). Base de données publique des médicaments, dernière mise à jour le 29/09/2026. (Propecia 1 mg : autorisation archivée.)
- Minoxidil Bailleul 5 %, solution pour application cutanée : résumé des caractéristiques du produit (rubriques 4.1 à 4.5). Base de données publique des médicaments, dernière mise à jour le 29/09/2026.
- Maruani A, Barbarot S, Gangneux JP, et al. Management of tinea capitis in children following the withdrawal of griseofulvin from the French market: a fast-track algorithm proposed by the Center of Evidence of the French Society of Dermatology. Ann Dermatol Venereol. 2022;149(4):238-240.
- Société française de dermatologie (centre de preuves), Société française de mycologie médicale, Société française de pédiatrie, Société française de dermatologie pédiatrique, SPILF. Teignes : algorithme de prise en charge des teignes de l'enfant après l'arrêt de la commercialisation de la griséofulvine en France. Élaboré en 2021, mis à jour en septembre 2026 (algorithme et bordereaux 1, 3, 4 et 5).
- Mayser P, Abeck D, Bosshard PP, et al. Consensus-based guideline on tinea capitis. J Dtsch Dermatol Ges. 2026;24(10):e1510-e1522.
- Agence nationale de sécurité du médicament et des produits de santé (ANSM). Traitement de la teigne de l'enfant et indisponibilité de la griséofulvine : l'ANSM précise la conduite à tenir. Publié le 9 juillet 2021, mis à jour le 4 juin 2026.
- Gangneux JP, Brun S, Menotti J, Botterel F. Role of the mycological diagnosis in the management of tinea capitis: French recommendations in the post-griseofulvin era. J Mycol Med. 2023;33(3):101379.
- Hôpitaux universitaires de Strasbourg, plateau technique de microbiologie. Prélèvement de peau ou de phanères pour examen mycologique avec recherche de dermatophytes. Mode opératoire PTM-R2-MOPE-038, version 3, applicable le 7 juillet 2026.
- Ely JW, Rosenfeld S, Seabury Stone M. Diagnosis and management of tinea infections. Am Fam Physician. 2014;90(10):702-710.
- Yongpisarn T, Tejapira K, Suchonwanit P. Comorbidities in primary cicatricial alopecia: a systematic review and meta-analysis. Front Immunol. 2025;16:1516407.